The FDA has approved numerous new medications in 2026. Review the latest approvals through June 24, 2026, and discover why staying current is essential for medication reconciliation, survey readiness, and patient safety.
March is Malignant Hyperthermia Awareness & Training Month—a vital reminder for ASCs to review protocols, train staff, and ensure readiness to manage MH emergencies effectively.